我国医药类上市公司经营近况分析

目的 :了解我国医药类上市公司经营近况。方法 :收集、整理我国医药类上市公司的经营业绩和财务状况 ,并进行分析和评价。结果 :2000年、2001年、2002年1季度～3季度医药类上市公司平均每股收益分别为0 26、0 1987、0 1412元 ,平均每股净资产分别为2 83、3 1139、3 2050元 ,平均每股净资产收益率分别为10 81 %、5 1189 %、2 3759 %。结论 :我国医药类上市公司新产品、生产规模、产值、资产逐年增加 ,但净资产收益率受药品降价、药品招标等政策影响逐年下降

Analysis of Current Situation of Business Performance of Listed Medical Companies in China

OBJECTIVE:To survey the current situation of business performance of listed medical companies in China METHODS:The data of financial and business status of listed medical companies in China were collected and analyzed in order to evaluate the developing potentials of these companies RESULTS:In the year 2000,2001 and the first 3 quarters of 2002,the average yield per stock,the net profit per stock and the net asset yield rate of China's listed medical companies were 0 26,0 1 987 and 0 1 412 yuans(RMB),2 83,3 1 139 and 3 2 050 yuans(RMB) and 10 81%,5 1 189% and 2 3 759% respectively CONCLUSION:The new products,production scale,production values and the net assets in China's listed medical companies increased year by year,whereas the net assets yield rate of these companies brought down due to the new policies such as decrease of drug price and public bidding for the medicine sale